(Incorporated in the Cayman Islands)

We are a newly organized blank check company. We intend to focus on acquiring a business at the intersection of technology and health.

David Berry, our chairman and CEO, brings over two decades of experience as an entrepreneur, operator, and investor at the forefront of healthcare and technology innovation. Before co-founding Averin, David served as a general partner at Flagship Pioneering Inc., where he founded or co-founded more than 20 companies across life sciences and sustainability, including seven that achieved valuations in excess of $1 billion.

(Note: Averin Capital Acquisition Corp. priced its SPAC IPO in sync with the terms in the prospectus – 25 million units at $10.00 each – to raise $250 million on Wednesday night, Feb. 18, 2026. Each unit consists of one share and one-sixth of one redeemable warrant. Background: Averin Capital Acquisition filed its S-1 on Jan. 30, 2026, and disclosed the terms for its SPAC IPO.)